CD133 has been used as a putative stem cell marker in glioblastoma [16] and colon cancer [9]; CD34 expressing tumour epithelial cells have been used as a marker in cutaneous cancer [17]; and CD44 expressing cells have been used as a marker in breast cancer [18]. The gene discussed is CD44; the disease is neoplasm.